wordpress blog stats
Connect with us

Hi, what are you looking for?

CCI approves MedLife-PharmEasy merger despite opposition from chemists’ body

Without disclosing any detail on the structure, the Competition Commission of India said it has approved the merger of MedLife with larger online pharmacy PharmEasy. The companies had filed for merger in August, and proposed a combination wherein API Holdings, the parent company of Pharmeasy will acquire a 100% stake in MedLife; in return, MedLife will acquire a 19.9% in the combined entity.

The merger has come through despite opposition from the Delhi-based South Chemists & Druggists Association, which argued that onlne pharmacies are not allowed under the law, and hence the CCI cannot permit “combination for an illegal purpose”.

In a representation to the CCI last week, the association had said that the proposed merger is essentially “that of two e-pharmacies as well as companies involved in the distribution chain”. It also said that the deep discounting by e-pharmacies can harm competition, given that these “are not based on any efficient business model but solely due to cash burn thanks to investment from foreign based entities”.

Thus, the resulting monopolistic market structure arising from the entry barriers created on account of network effects, coupled with the exit of efficient competitors from the market, cannot be easily self-corrected by market forces.

Since the e-pharmacies are any ways operating without any license, the combined entity would exploit the entire set up for its own benefit, at great cost of competition in the market. The combination would adversely distort the market, since the small retailers, offline chemists cannot integrate the distribution and retail sale under one umbrella due to license conditions, nor have the capacity to do so. SCDA

This merger in the online pharmacy space is the first since the entry of bigger players such as Reliance and Amazon into online medicine delivery space. Reliance Retail acquired a 60% stake in the Vitalic Health, parent company of Chennai-based NetMeds. The deal granted Reliance Retail 100% ownership of Vitalic’s subsidiaries NetMeds Marketplace, Tresara Health, and Dadha Pharma Distribution. Amazon also launched their online pharmacy in Bangalore, and began taking orders for prescription-based and over-the-counter medicines, “basic health devices”, and Ayurveda medication.

You May Also Like


The Competition Commission of India has sought information from sellers body AIOVA on the alleged preferential treatment that Amazon gives to certain large sellers,...


The Delhi High Court on Monday refused to stop Amazon from pushing regulators to stop the sale of the Future Group’s businesses to Reliance...


Facebook says it will start removing debunked misinformation about the upcoming COVID-19 vaccines in the coming weeks. The removals will be part of Facebook’s...


India’s apex drug regulator has granted medical device registration to three wearable devices from GOQii, the California-based fitness technology company. These devices offer measurements...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2018 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to Daily Newsletter

    © 2008-2018 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ